Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-10

Clinical Trial Update: Efficacy of Methylprednisolone for Hantavirus Cardiopulmonary Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating methylprednisolone for hantavirus cardiopulmonary syndrome completed; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: University of New Mexico | Conditions: Hantavirus Infections | Phase 2 | Status: COMPLETED | Results posted: 2012-07-10